![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.65 | 4.52 | 4.99 | - | 172,565 | 10:52:51 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/7/2020 16:17 | DNL EXPLODINGGGGGGGGGGGG DNL = 3x Approvals expected during next 2 months including an Orphan Drug with FDA decision on September 29 = CHEAPEST UK Biotech a potential 500%++ GEM Market Cap £45 million Cash £15 million or Cash untill early 2022 Price 48p Alkindi approval in Australia expected this Quarter Alkindi approval in Israel expected this Quarter FDA decision for Alkindi on September 29 EMA Decision for Chronocort expected in early Q1 2021 US-Partnership for Chronocort (Phase3 ready) in 2H 2020 | ih_752952 | |
29/7/2020 16:08 | O/t - VAL worth a good look imo.A very good q&A on the website. Anwers lots of questions and am confident in Dr Dilly. Already reduced annual staff remuneration from GBP 900k to about GBP 300kRight now market cap is just GBP 4m with over GBP 2m of cash. | ![]() jungmana | |
29/7/2020 15:46 | Broker said 360p but with approval no upper limit!!!!!That says all we need to know! | ![]() dave444 | |
29/7/2020 15:41 | Price has held well over recent sessions. Waiting for development. Anybody's guess where it could go from here on good progress. | ![]() allin | |
29/7/2020 15:40 | Very high. Just IMHO of course.... | ![]() nobbygnome | |
29/7/2020 15:39 | Nobby...whats your opinion on the chances of SNG001 being granted a special licence to allow the public to be treated without having to wait for a large phase 3 study? | ![]() kop202 | |
29/7/2020 15:24 | That expert opinion contains some good analysis....and some appalling uninformed comment. The wide difference in the views from these so callled experts shows that you will get as many views as experts you ask. All that matters is what the regulators say.... | ![]() nobbygnome | |
29/7/2020 15:10 | no doubt walked down for an order filling, another TR1? News must be so close on peer review, approval or deal or COPD results. | ![]() jambam | |
29/7/2020 15:08 | Thanks for the link. | ![]() eggy toast | |
29/7/2020 15:04 | Very interesting that they will take my entire holding (well over £100k) in one go well above bid....think we will see this move significantly higher by the weekend. | oranolio |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions